Johns Hopkins Drug Discovery - John Hopkins University
The Johns Hopkins Drug Discovery Program continues to work with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide range of human disorders.
Johns Hopkins, Drug Discovery, Transforming academic translational research
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive
Johns Hopkins University Drug Discovery

Transforming academic
translational research


Expertise in drug
discovery research


Developing for the future

What’s New?

Startup with Johns Hopkins roots raising $40.5 million to develop cancer metabolism drugs

Click here to read more

JHDD receives 3 TEDCO Maryland Innovation Initiative Awards
-Developing an inhibitor of neutral sphinghomyelinase2 for the treatment of Alzheimer’s disease (Rojas)

-Developing a therapeutic to prevent kidney toxicity in prostate cancer patients receiving PSMA-targeted radiotherapy (Slusher)

-Develop a potent drug with a novel mechanism for the treatment of leukemia and lymphoma (Slusher)

Click here to read more

JHDD receives grant award from Crohn’s and Colitis Foundation for IBD in the amount of $350K

Click here to read more

Building innovative partnerships

Johns Hopkins University Drug Discovery - JHU Drug Discovery

Our HTS collaboration with Eisai and partnership with IOCB represent innovative ways to create a great synergy of complimentary organizations working together to develop new therapeutics.

Interested in Working With Us?

Johns Hopkins University Drug Discovery - JHU Drug Discovery

We welcome opportunities to discuss how we can work together in various capacities including laboratory services, drug discovery collaborations, and industrial collaborations.

Login to iLab to submit a proposal to JHDD.